2:PN:US20040072744 SEQID:2 claimed protein
CAS No. 389572-87-6
2:PN:US20040072744 SEQID:2 claimed protein( —— )
Catalog No. M29969 CAS No. 389572-87-6
2: PN: US20040072744 SEQID: 2 claimed protein is a synthetic peptide, used for the research of Down’s syndrome and schizophrenia.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 3645 | Get Quote |
|
| 10MG | 6156 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
Biological Information
-
Product Name2:PN:US20040072744 SEQID:2 claimed protein
-
NoteResearch use only, not for human use.
-
Brief Description2: PN: US20040072744 SEQID: 2 claimed protein is a synthetic peptide, used for the research of Down’s syndrome and schizophrenia.
-
Description2: PN: US20040072744 SEQID: 2 claimed protein is a synthetic peptide, used for the research of Down’s syndrome and schizophrenia.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number389572-87-6
-
Formula Weight1070.13
-
Molecular FormulaC43H67N13O17S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameSequence:Asn-Leu-Gly-Glu-His-Pro-Val-Cys-Asp-Ser
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Fructo-oligosacchari...
Fructo-oligosaccharide DP9/GF8 belongs to fructooligosaccharides (FOS) with the degree of polymerization (DP=9).
-
Physostigmine
Physostigmine (Eserine) is a reversible acetylcholinesterase (AChE) inhibitor. Physostigmine can crosses the blood-brain barrier and stimulates central cholinergic neurotransmission. Physostigmine can reverse memory deficits in transgenic mice with Alzheimer's disease. Physostigmine is also an antidote for anticholinergic poisoning.
-
Manool
Manool, a diterpene from Salvia miltiorrhiza, showed antitumor activity in a mouse melanoma model.Manool caused cell cycle arrest in the G(2)/M phase of cancer cells, reducing the prevention of chromosomal damage and precancerous lesions.
Cart
sales@molnova.com